4.5 Article

Isoprostanes as Biomarker for Patent Ductus Arteriosus in Preterm Infants

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pediatrics

Application of NPE in the assessment of a patent ductus arteriosus

David van Laere et al.

PEDIATRIC RESEARCH (2018)

Review Pediatrics

Reflections of the changes in patent ductus arteriosus management during the last 10 years

Afif EL-Khuffash et al.

ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION (2016)

Article Obstetrics & Gynecology

Development of a fast and simple LC-MS/MS method for measuring the F2-isoprostanes in newborns

Bruno Casetta et al.

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2012)

Article Biochemistry & Molecular Biology

Contractile effects of 15-E2t-isoprostane and 15-F2t-isoprostane on chicken embryo ductus arteriosus

Saskia van der Sterren et al.

COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR & INTEGRATIVE PHYSIOLOGY (2011)

Review Pediatrics

Patent Ductus Arteriosus of the Preterm Infant

Shannon E. G. Hamrick et al.

PEDIATRICS (2010)

Article Pediatrics

Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management

JM Brooks et al.

ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION (2005)

Article Biochemistry & Molecular Biology

Plasma F2-isoprostanes are elevated in newborns and inversely correlated to gestational age

M Comporti et al.

FREE RADICAL BIOLOGY AND MEDICINE (2004)

Article Biochemistry & Molecular Biology

F2-isoprostane and prostaglandin F2α metabolite excretion rate and day to day variation in healthy humans

J Helmersson et al.

PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2001)